INTRODUCTION
============

The accumulation of modified or damaged bases in genomic DNA is a major threat for the alteration of genetic information as a result of mutagenesis or even for programmed cell death. It has been established that such damaged bases in genomic DNA arise from two independent pathways: one is a consequence of the direct modification of the normal bases in the DNA and the other is that of the incorporation of modified nucleotides generated in resident nucleotide pools ([@B1],[@B2]).

To control the quality of the nucleotide pools, organisms possess a number of nucleoside triphosphatases, which degrade non-canonical nucleoside triphosphates to the corresponding monophosphates. We had identified and characterized three mammalian enzymes: (i) oxidized purine nucleoside triphosphatase encoded by *MTH1* gene for 8-oxo-2′-deoxyguanosine triphosphate (8-oxo-dGTP), 8-oxoGTP, 2-hydroxy-2′-deoxyadenosine triphosphate (2-OH-dATP) and 2-OH-ATP ([@B3],[@B4]); (ii) inosine triphosphatase encoded by *ITPA* gene for deaminated purine nucleoside triphosphates such as 2′-deoxyinosine triphosphate (dITP), ITP and 2′-deoxyxanthosine triphosphate (dXTP) and XTP ([@B5],[@B6]); and (iii) a newly discovered enzyme, dCTP pyrophosphatase encoded by *DCTPP1* gene for halogenated dCTPs such as 5-iodo-2′-deoxycytidine triphosphate ([@B7]).

To clarify the biological significance of the damaged nucleotides and the enzymes that eliminate them, we had previously produced and analyzed knockout mice lacking MTH1 or ITPA. *Mth1^−/--^* mice are viable and survive normally but exhibit an increased incidence of spontaneous tumorigenesis in the liver, stomach and lung ([@B8]), while *Itpa^−/--^* mice die before weaning with features of growth retardation and heart failure ([@B6]).

ATP, the most abundant of the nucleotides, plays a fundamental role in a wide variety of cellular processes, including energy transfer, signal transduction, RNA synthesis, cytoskeleton remodeling and muscle contraction. Deamination of adenine at C-6 converts ATP to ITP; such modification is catalyzed by enzymes such as adenosine or AMP deaminase ([@B9]), or induced chemically under oxidative stress ([@B7]). Because ITP retains a molecular structure similar to that of ATP, it can act as an aberrant substrate replacing ATP in some biological processes ([@B10],[@B11]). In the case of cardiac function, a number of sarcomere proteins require ATP for their normal activities. It is likely that during cardiac development in *Itpa^−/--^* mice the accumulated ITP competes with ATP, which is required for actomyosin function in the sarcomere, thus causing heart failure ([@B6]).

Bradshaw and Kuzminov ([@B12]) reported that an *Escherichia coli* mutant of *rdgB* gene-encoding inosine triphosphatase has no obvious phenotype; however, the mutant exhibits synergistic lethality in the presence of *recA* or *recBC* mutations. They concluded that RdgB acts to avoid incorporation of 2′-deoxyinosine (dI) in DNA and thereby blocks chromosome fragmentation by hydrolyzing dITP in *E. coli*. These observations strongly suggest that ITPA deficiency in mouse cells also causes chromosomal abnormalities.

In the present study, we examined mouse embryonic fibroblasts (MEFs) prepared from wild-type (*Itpa^+/+^*), *Itpa^+/−^* and *Itpa^−/--^* embryos to explore the cellular dysfunction caused by ITPA deficiency. We found that *Itpa^−/--^* embryos accumulated more than eight times higher levels of dI in nuclear DNA than did wild-type embryos. Moreover, *Itpa^−/--^* primary MEFs with no ITP-hydrolyzing activity exhibited prolonged doubling times, increased chromosome aberrations and accumulation of single-strand breaks in nuclear DNA. Surprisingly, these phenotypes all disappeared following immortalization of *Itpa^−/--^* MEFs, with a significant increase in IDP-hydrolyzing activity accompanied by a decreased accumulation of dI in nuclear DNA. We have thus identified a novel enzyme which constitutes a dual enzyme system for eliminating dITP/ITP and dIDP/IDP from nucleotide pools together with ITPA in mammals.

MATERIALS AND METHODS
=====================

Nucleotides
-----------

Nucleotides used as substrates for enzyme assay were purchased from Sigma-Aldrich (St Louis, MO, USA), or Jena Bioscience GmbH (Jena, Germany). Separation and purification of nucleotides were performed on a Waters Alliance 2690 HPLC separation module (Waters Corp., Milford, MA, USA) equipped with a Model 996 photodiode array detector and a Wakopak Handy ODS column (4.6 × 250 mm) using 100 mM triethyl ammonium hydrogen carbonate solution (pH 7.4) (Wako Pure Chemicals, Osaka, Japan) as the mobile phase. Purified nucleotides were lyophilized five times with solubilization in distilled water.

*Itpa* gene knockout mice
-------------------------

*Itpa* gene knockout mice were established as described ([@B6]). Genotypes were analyzed using tail DNA. PCR primers used to detect the wild-type and *Itpa* mutant alleles were P46 and P47, or P29 and LNEO1, respectively ([Supplementary Table S2](http://nar.oxfordjournals.org/cgi/content/full/gkp1250/DC1)). Heterozygous male (*Itpa^+/−^*) were backcrossed with C57BL/6J female (*Itpa^+/+^*) (Clea Japan, Tokyo, Japan) for more than five generations (*N* \> 5). All animals were maintained in an air-conditioned, light/time-controlled, specific-pathogen-free room. All studies were approved by the Animal Care and Use Committee, Medical Institute of Bioregulation, Kyushu University.

Preparation of primary and immortalized MEFs
--------------------------------------------

Twenty embryonic gestation day (E)13.5 and E14.5 embryos were obtained by intercross mating of inbred N10 or N11 *Itpa^+/−^* mice (three pairs). Their genotypes were *Itpa^+/+^*, *Itpa^+/−^* and *Itpa^−/--^* at a ratio of 5:10:5. Skin fibroblasts were aseptically isolated from these embryos and at least four independent embryos were used for each genotype (*Itpa^+/+^*, *Itpa^+/−^*, *Itpa^−/--^*). These primary MEFs were cultured in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (FBS), 100 units/ml penicillin and 100 µg/ml streptomycin at 37°C under 5% CO~2~ in air. Primary MEFs in culture were harvested by treatment with 0.15% trypsin--0.08% EDTA in PBS and replated for further passage. Those from Passage 2 were stocked as primary MEFs. Spontaneously immortalized MEFs were established after single colony isolation during 30--40 passages. Their genotypes were determined by genomic polymerase chain reaction (PCR) amplification and three lines of immortalized MEFs were independently established from three embryos for each genotype.

Cell proliferation assays
-------------------------

Primary or immortalized MEFs were seeded at 1 × 10^5^ cells ([Figures 1](#F1){ref-type="fig"}C and [4](#F4){ref-type="fig"}A) or 0.5 × 10^5^ cells ([Figure 7](#F7){ref-type="fig"}C) per well in six-well plates (Nalge Nunc International K.K., Tokyo, Japan). Cells were harvested every 2 days or every day, respectively, and the numbers of cells were counted using a hemocytometer. Figure 1.ITPA*-*deficient primary MEFs exhibit various cellular dysfunctions. (**A**) ITPA deficiency caused a significantly increased accumulation of inosine in cellular RNA. Inosine level was determined by LC--MS/MS analysis of cellular RNA prepared from embryos (N3). Result of non-repeated measures ANOVA (two-tailed), *P* = 1.69 × 10^−7^. Student--Newman--Keuls (SNK) *post hoc* test, \*\**P* \< 0.01 (versus *Itpa^+/+^* and *Itpa^+/−^*). Data are shown as the mean ± SD (*n* = 3 independent embryos). (**B**) ITPA deficiency caused a significantly increased accumulation of deoxyinosine (dI) in nuclear DNA. Deoxyinosine (dI) level was determined by LC--MS/MS analysis of nuclear DNA prepared from embryos (N3). Result of non-repeated measures ANOVA (two-tailed), *P* = 0.00038. SNK *post hoc* test, \*\**P* \< 0.01 (versus *Itpa^+/+^* and *Itpa^+/−^*). Data are shown as the mean ± SD (*n* = 3 independent embryos). (**C**) ITPA deficiency impairs normal cell proliferation. Primary MEFs (Passage 2) isolated from four separate *Itpa^−/--^* embryos showed significant prolonged doubling time in comparison to those from *Itpa^+/+^* and *Itpa^+/−^* embryos. Result of repeated measures ANOVA (two-tailed), *P* = 0.0005. Bonferroni/Dunn *post-hoc* test, \**P* \< 0.05 (versus *Itpa^+/−^*), \*\**P* \< 0.01 (versus *Itpa^+/+^*). Data are shown as the mean ± SD (*n* = 4 independent MEFs). (**D**) ITPA deficiency causes G2/M arrest. Primary MEFs (Passage 5) were subjected to flow cytometry analysis and the percentages of Cell-cycle phases in each MEF set were determined. Result of non-repeated measures ANOVA (two-tailed), *P* = 1.74 × 10^−8^. Bonferroni *post hoc* test, \*\**P* \< 0.01 (versus *Itpa^+/+^* and *Itpa^+/−^*). Data are shown as the mean ± SD (*n* = 3 independent isolates). Figure 2.Increased DNA content in ITPA deficient primary MEFs. (**A**) Flow cytometric analysis of the cell cycle was performed and the sub G1 fraction (M1), diploid fraction (M2) and a fraction with an increased DNA content (M3) were determined. (**B**) ITPA deficiency increased chromosomal ploidy in primary MEFs. Percentages of diploid, tetraploid and others are shown in pie charts with the mean ± SD (three independent isolates). The frequency of tetraploidy was increased significantly in *Itpa^−/--^* MEFs. Results show non-repeated measures ANOVA (two-tailed): *P =* 0.094. *P*-value is shown following a Bonferroni *post hoc* test. Figure 3.ITPA deficiency increases chromosome abnormalities with increased accumulation of SSBs in nuclear DNA. (**A**) Various chromosome structural abnormalities were observed in *Itpa^−/--^* primary MEFs (Passage 2). (**B**) ITPA deficiency increases chromosome abnormalities. The frequency of chromosomal abnormality was significantly increased in *Itpa^−/--^* MEFs in comparison to *Itpa^+/+^* and *Itpa^+/−^* MEFs. Result of non-repeated measures ANOVA (two-tailed), *P* = 0.0149. Bonferroni *post hoc* test, *P* \< 0.01. Data are shown as pie charts with the mean ± SD (*n* = 4 independent isolates). (**C**) Detection of immunoreactivity against ssDNA in *Itpa^−/--^* primary MEFs. Immunofluorescence microscopy with anti-ssDNA antibody (green) revealed significantly increased ssDNA immunoreactivity in nuclei (DAPI, blue) of *Itpa^−/--^* primary MEFs (Passage 2) compared with the wild-type (*Itpa^+/+^*). (**D**) Significant Increase in the ssDNA-positive population in *Itpa^−/--^* primary MEF tested by unpaired Student's *t*-test (two-tailed): \*\**P* \< 0.01. Data are shown in a bar graph (mean ± SD, *n* = 4 independent isolates). Figure 4.ITPA-deficient phenotypes are reversed during immortalization. (**A**) Immortalized *Itpa^−/--^* MEFs (triangle) showed the same proliferation rate as did immortalized *Itpa^+/+^* (circle) and *Itpa^+/−^* (square) MEFs. Error bars represent the SD (*n* = 3 independent isolates). (**B**) The frequency of chromosomal abnormalities was decreased in immortalized *Itpa^−/--^* MEFs to the levels seen in immortalized *Itpa^+/+^* MEFs. Data are shown as the mean ± SD (*n* = 3 independent isolates). Figure 5.Increased DNA content in ITPA deficient immortalized MEFs. (**A**) Flow cytometric analysis of the cell cycle was performed and the sub G1 fraction (M1), diploid fraction (M2) and a fraction with an increased DNA content (M3) were determined. (**B**) ITPA deficiency increased chromosomal ploidy in immortalized MEFs. Percentages of diploid, tetraploid and others are shown in pie charts with the mean ± SD (three independent isolates). The frequency of tetraploidy was increased significantly in *Itpa^−/--^* MEFs. Results show non-repeated measures ANOVA (two-tailed): *P =* 0.00015. *P*-values are shown following a Bonferroni *post hoc* test. Figure 6.NUDT16 with strong dIDP/IDP-hydrolyzing activity is the back-up enzyme responsible for the cancellation of ITPA-deficient phenotypes during immortalization. (**A**) Expression of *Nudt16* mRNA. Quantitative real-time RT--PCR was performed to compare *Nudt16* mRNA levels between primary (passage 3) and immortalized MEFs. Levels of *Nudt16* mRNA were normalized to those of *Gapdh* mRNA. Values relative to the highest level of *Nudt16* mRNA in immortalized *Itpa^−/--^* MEFs (isolate No. 3) are shown. Unpaired Student's *t*-test (two-tailed) showed *P* \< 0.01 between primary and immortalized *Itpa^−/--^* MEFs. Data are shown in a bar graph (mean ± SD), with fold changes between primary and immortalized MEFs (*n* = 3 independent isolates). Open and black bars show primary MEFs; shaded bars indicate immortalized MEFs. (**B**) Expression of NUDT16 protein. Western blotting was performed for crude cell extracts (40 µg) prepared from primary (Passage 2) and immortalized MEFs, using anti-NUDT16 antibody (top). GAPDH was detected as an internal control (middle). Membranes were stained with Gel Code Blue in order to confirm the loading and transfer (bottom). Intensities of NUDT16 bands were measured and relative levels normalized to GAPDH are shown in a bar graph. Open and black bars show primary MEFs; shaded bars indicate immortalized MEFs. Result of non-repeated measures ANOVA (two-tailed), *P* \< 0.019. Bonferroni *post hoc* test, \*\**P* \< 0.01 (versus others). Error bars represent the SD (*n* = 3 independent isolates). Figure 7.Knockdown of *Nudt16* mRNA suppressed ITPA-deficient phenotypes in immortalized *Itpa^−/--^* MEFs. (**A**) Expression of *Nudt16* mRNA. To knock down the expression of *Nudt16*, two different siRNAs (80, 82 or 80 + 82) against *Nudt16* mRNA or control siRNA were introduced into immortalized *Itpa^−/--^* MEFs. Forty-eight hours after the introduction, total RNA was prepared and quantitative real-time RT--PCR was performed. Levels of *Nudt16* mRNA were normalized to those of *Gapdh* mRNA and their relative values are shown. Data are shown in a bar graph (mean ± SD, *n* = 3). (**B**) Expression of NUDT16 protein. Western blotting was performed for crude cell extracts (40 µg) prepared from immortalized *Itpa^−/--^* MEFs treated with two *Nudt16* siRNAs (80 + 82) or control siRNA, using anti-NUDT16. GAPDH was detected as an internal control. (**C**) Knockdown of *Nudt16* mRNA suppressed proliferation of immortalized *Itpa^−/--^* MEFs. Expression of *Nudt16* mRNA was blocked using a mix of two different *Nudt16* siRNAs and cell proliferation was examined. Circles, *Itpa^+/+^*; triangles, *Itpa^−/--^*; open marks, control siRNA; closed marks, *Nudt16* siRNAs. Result of repeated measures ANOVA, two-tailed, *P* \< 0.0001; Bonferroni/Dunn *post hoc* test, \*\**P* \< 0.01 (versus other three measures). Error bars represent the SD (*n* = 4). (**D**) Knockdown of *Nudt16* mRNA significantly increased the accumulation of inosine in RNA of immortalized *Itpa^−/--^* MEFs. Level of inosine in RNA was determined by LC--MS/MS analysis of RNA prepared from immortalized *Itpa^−/--^* MEFs treated with control or *Nudt16* siRNAs. Result of unpaired Student's *t*-test (two-tailed), \*\**P* \< 0.01. Data are shown as a bar graph with the mean ± SD (*n* = 3). (**E**) Knockdown of *Nudt16* mRNA significantly increased the accumulation of dI in nuclear DNA of immortalized *Itpa^−/--^* MEFs. Level of dI in nuclear DNA was determined by LC--MS/MS analysis of nuclear DNA prepared from immortalized *Itpa^−/--^* MEFs treated with control or *Nudt16* siRNAs. Result of unpaired Student's *t*-test (two-tailed), \*\**P* \< 0.01. Data are shown as a bar graph with the mean ± SD (*n* = 3). (**F**) Increased immunoreactivity against ssDNA in immortalized *Itpa^−/--^* MEFs after *Nudt16* knockdown. Immunofluorescence microscopy with anti-ssDNA antibody revealed significantly increased immunoreactivity after *Nudt16* knockdown. Result of unpaired Student's *t*-test (two-tailed), \*\**P* \< 0.01. Data are shown as a bar graph with the mean ± SD (*n* = 4). (**G**) Knockdown of *Nudt16* mRNA increased chromosomal abnormalities in immortalized *Itpa^−/--^* MEFs. The frequency of chromosomal abnormalities was increased significantly in immortalized *Itpa^−/--^* MEFs after *Nudt16* knockdown. Result of unpaired Student's *t*-test (two-tailed), *P* \< 0.05 (versus control siRNA). Data are shown as pie charts with the mean ± SD (*n* = 4).

Cell-cycle analysis
-------------------

Flow cytometric analysis of the cell cycle was performed as described ([@B13]). Cells (1 × 10^6^ cells per assay) were centrifuged, washed with phosphate buffered saline (PBS) and suspended in PBS containing 0.2% Triton X-100. We then added 5 µl of RNase A (1 mg/ml) and 50 µl of propidium iodide (PI, 1 mg/ml). DNA content and cell numbers were analyzed with an LSR flow cytometer (Becton Dickinson, San Jose, CA, USA). The data were analyzed using CellQuest and ModFit software (Becton Dickinson).

Karyotype analysis
------------------

A 50% confluent culture of MEFs was treated with 0.1 µg/ml colcemid (Nacalai Tesque Inc., Kyoto, Japan) for 30 min. After hypotonic treatment of harvested cells in 75 mM KCl, cells were fixed in freshly prepared Carnoy's fixative (methanol:acetic acid 3:1), and the cell suspension was dropped onto a glass slide, air-dried and immediately stained with freshly prepared Giemsa staining solution (Merck KGaA, Darmstadt, Germany cat. no. 1.09204.0509, 25× diluted in PBS) for 20 min. After rinsing the slide in PBS twice and in distilled water twice, air-dried slides were cover-slipped using Permount (Fisher Scientific, Waltham, MA, USA; SP15-100). The slide was observed under an Axioscope 2 plus microscope equipped with AxioCam and AxioVision software (Carl Zeiss MicroImaging Japan, Tokyo, Japan). A total 30 cells in metaphase was examined for each preparation.

Quantification of deoxyinosine or inosine by liquid chromatography coupled with tandem mass spectrometry
--------------------------------------------------------------------------------------------------------

The preparation and digestion of nuclear DNA samples were as described ([@B14]), except that 10 mM 2, 2, 6, 6-tetramethylpiperidine-*N*-oxyl (TEMPO, Wako Pure Chemicals) and 20 µM 2′-deoxycoformycin (a kind gift from the Chemo-Sero-Therapeutic Research Institute, Kumamoto, Japan), an adenosine deaminase inhibitor, was added at all stages of manipulation, as described by Taghizadeh *et al.* ([@B15]). RNA was prepared using RNeasy Mini Kits (Qiagen Inc., Valencia, CA, USA) according to the manufacturer's instructions in the presence of 20 mM TEMPO and 20 µM 2′-deoxycoformycin. DNA or RNA samples were digested with nuclease P1 (Yamasa, Chiba, Japan) and alkaline phosphatase (Sigma-Aldrich, P-5521) and digested samples were subjected to LC--MS/MS analysis using the Shimadzu VP-10 HPLC system (SHIMADZU CORPORATION, Kyoto Japan) connected to the API3000 MS/MS system (PE-SCIEX, Applied Biosystems, Foster City, CA, USA), as described ([@B14]).

Immunostaining
--------------

To detect single-stranded (ss) DNA, the slides were incubated with anti-ssDNA (IBL, Takasaki, Japan; code number 18 731, 1/100 dilution) in combination with Alexa Fluor 488-conjugated goat anti-rabbit IgG (Invitrogen, Carlsbad, CA. USA), as described ([@B16]). Nuclei were counterstained with 4′, 6-diamino-2-phenylindole (DAPI, 50 ng/ml; Vector, Burlingame, CA, USA). A cover slide was mounted onto the slide with Vectashield (Vector). The slide was observed using an Axioskop 2 plus microscope equipped with AxioCam and AxioVision software (Carl Zeiss MicroImaging Japan). A total of 100 cells were examined for each preparation.

Inosine triphosphatase and Inosine diphosphatase assays
-------------------------------------------------------

Embryo samples or pellets of immortalized MEFs (1 × 10^7^ cells) were washed twice with PBS and quickly frozen in liquid nitrogen. Frozen samples in 100 µl of lysis buffer containing 50 mM Tris--HCl (pH 8.0), 50 mM NaCl, 1 mM dithiothreitol and protease inhibitor cocktail (Nacalai Tesque), were sonicated at 4°C. The lysate was centrifuged at 17 360 × *g* for 60 min and the supernatant was collected as a crude cell extract. The protein concentration was determined with a Protein Assay system (Bio-Rad, Hercules, CA, USA) using bovine serum albumin (Thermo Fisher Scientific Inc., Waltham, MA, USA) as a standard. Inosine triphosphatase or Inosine diphosphatase activities were assayed by measuring the hydrolysis of ITP or IDP to IMP. The reaction mixture contained 50 mM Tris--HCl (pH 8.5), 50 mM MgCl~2~, 1 mM DTT, 0.2 mM ITP or IDP and 1--10 µg of the crude-cell extract to be examined. The reaction was run at 30°C for 20 min and stopped by adding 150 mM EDTA. The reaction mixture was applied to HPLC analysis as described ([@B6]). Separation and quantification of nucleotides were performed by HPLC using a Waters Alliance 2690 separation module equipped with a Model 996 photodiode array detector. A buffer consisting of 75 mM sodium phosphate (pH 6.4), 0.4 mM EDTA, with 20% acetonitrile was used as the mobile phase in a TSK-GEL DEAE-2SW column, 4.6 × 250 mm (Tosoh Corp., Tokyo, Japan).

Quantitative real-time reverse transcription polymerase chain reaction
----------------------------------------------------------------------

MEFs were seeded at 1 × 10^5^ cells per well with 500 µl of medium in 24-well plates and cultured to 70--80% confluency, or for 3 days. RNA was extracted from the harvested cells using an Isogen kit (Nippon Gene Inc., Tokyo, Japan). Totally 2 µg of total RNA was subjected to RNase-free DNase I treatment and cDNA synthesis using random decamers and a Cells-to-cDNA II kit (Ambion), according to the manufacturer's instructions. Quantitative real-time PCR was performed using an ABI Prism 7000 sequence detection system with 10 ng cDNA, a set of *Nudt16* primers (FmNud3RT, RmNud3RT; 200 nM) or a set of *Gapdh* primers (F-Gapdh, R-Gapdh; 50 nM) and Power SYBR Green PCR Master Mix (Applied Biosystems) in a total volume of 25 µl. The PCR reaction was performed as follows: a single cycle of 50°C for 2 min, a single cycle of 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. The primers were designed using PRIMER EXPRESS software (Applied Biosystems) and their sequences are shown in [Supplementary Table S2](http://nar.oxfordjournals.org/cgi/content/full/gkp1250/DC1). Specificity of the PCR products was established by dissociating curve analysis and by running the products on a 2% agarose gel to verify their size. The *Nudt16* mRNA level is expressed relative to the *Gapdh* mRNA level. Serially diluted cDNA was used to obtain a standard curve for each transcript.

Western blotting
----------------

MEFs were seeded at 5 × 10^5^ cells per dish in 10 ml medium in a 90 mm Petri dish (Nalge Nunc International K.K.) and were cultured to 70--80% confluency or for 3 days. Cells were washed twice with PBS and harvested using 2× SDS sample buffer \[125 mM Tris--HCl (pH 6.8), 4% SDS, 10% glycerol, 4% 2-mercaptoethanol\]. The protein concentration was determined using a Protein Assay system as above. Protein samples were separated by SDS--PAGE and transferred to 0.45 µm Immobilon-P membrane (Millipore Inc., Madison, WI, USA) and western blot analysis using anti-hNUDT16 (1 µg/ml) or anti-ITPA antiserum (1/500 dilution) ([@B5]) with horseradish peroxidase-conjugated protein A and an ECL-Plus kit (GE Healthcare Bio-Sciences, Piscataway, NJ, USA) was performed as described ([@B17]). The same membrane was treated with WB stripping solution (Nacalai Tesque) and reprobed with anti-GAPDH (Millipore, Inc., Billerica, MA, USA; MAB374, 10^5^× diluted) and HRP-anti-mouse IgG (BD Biosciences, San Jose, CA, USA).

Expression of recombinant mouse NUDT16 protein
----------------------------------------------

An expression vector for the mouse NUDT16 protein was constructed by inserting the NdeI-HindIII fragment of pET28a(+):mNudt16 into the NdeI-HindIII region of pET32a(+) (Merck KGaA), thus Trx·Tag-His·Tag-S·Tag sequences were removed. *Escherichia coli* BL21 cells were transfected with pET32a(+) vector or pET32a:mNudt16 using a Cell-porator (Life Technologies, Carlsbad, CA, USA) according to the manufacturer\'s; instructions. Transformants were selected on LB-agar plates in the presence of 30 µg/ml ampicillin. Established transformants were cultured until the OD~600~ reached 0.6 and then incubated with 1 mM isopropyl β-[d]{.smallcaps}-thiogalactoside for a further 3 h. Cells were harvested by centrifugation and resuspended in 1 ml of 2× SDS sample buffer. Samples were subjected to 12.5% SDS--PAGE and the expression of mouse NUDT16 protein without tag was confirmed by western blotting.

Introduction of silencing RNA into immortalized MEFs
----------------------------------------------------

*Nudt16* siRNA (Ambion/Applied Biosystems, Austin, TX, USA; *Silencer* Select; s93780, s93782, 25 µM) or control siRNA (Ambion/Applied Biosystems, *Silencer* Select Negative Control \#1 siRNA, cat. no. 4390844) was introduced into immortalized MEFs (*Itpa^+/+^*, *Itpa^−/--^*) by electroporation using a MicroPorator-mini (Digital Bio Technology, Seoul, Korea, MP-100, 1100 V, 10 ms for 2 pulses) and cells were replated appropriately into six-well plates 1 day after electroporation for further analysis.

Statistical analysis
--------------------

Statistical analysis was performed using Stat View 5.0 (SAS Institute Inc., Cary, NC, USA). The statistical signiﬁcance between two groups was determined with Student's *t*-test, and that among more than three groups was determined with non-repeated or repeated measures ANOVA with an appropriate correction for multiple comparisons as described in each figure legend. *P*-values \<0.05 are considered statistically significant.

RESULTS
=======

ITPA deficient primary MEFs exhibit various cellular dysfunctions
-----------------------------------------------------------------

*Itpa^−/--^* mice with a 129·C57BL/6J mixed genetic background exhibited incomplete embryonic lethality and the surviving pups die about 2 weeks after birth with growth retardation and heart failure ([@B6]). After backcrossing the heterozygotes (*Itpa^+/−^*) to C57BL/6J mice for more than five generations (N5), intercrosses of the obtained *Itpa^+/−^* mice yielded *Itpa^−/--^* embryos in uterus in accordance with Mendel's laws until embryonic gestation day (E) 18, but there were few newborn pups ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkp1250/DC1)), indicating that ITPA deficiency causes perinatal lethality in a C57BL/6J genetic background.

We confirmed significantly increased accumulation of inosine (567.3 ± 41.4 residues per 10^6^ guanosine) in cellular RNA prepared from *Itpa^−/--^* embryos (N14) in comparison to those from *Itpa^+/+^* (10.5 ± 1.50) and *Itpa^+/−^* (11.4 ± 1.07) embryos by liquid chromatography coupled with tandem mass spectrometry (LC--MS/MS) analysis ([Figure 1](#F1){ref-type="fig"}A), as previously observed in various tissues of surviving *Itpa^−/--^* pups ([@B6]).

Furthermore, LC--MS/MS analysis of nuclear DNA prepared from embryos revealed that *Itpa^−/--^* embryos (E14.5) obtained from intercrosses of *Itpa^+/−^* mice (N3) contained significantly more dI in their nuclear DNA (20.1 ± 4.8 residues per 10^6^ nucleosides): more than eight times that measured in *Itpa^+/+^* embryos (2.34 ± 0.76) ([Figure 1](#F1){ref-type="fig"}B). The increased dI levels were also confirmed in *Itpa^−/--^* embryos after further backcrossing to C57BL/6J mice (N14, E13.5, 24.5 ± 2.24 dI residues per 10^6^ nucleosides).

To examine the nature of the cellular dysfunction caused by ITPA deficiency, we isolated embryos (at E13.5 and E14.5) from intercrosses of *Itpa^+/−^* littermates (N10, one pair; N11, two pairs) and determined their genotypes ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkp1250/DC1)). Among 20 embryos, five were found to be *Itpa^−/--^*, 10 were *Itpa^+/−^* and the remaining five were *Itpa^+/+^*. Then we isolated primary MEFs independently from four embryos of each genotype and their genotypes and the expression levels of ITPA protein were confirmed ([Supplementary Figure S1A and B](http://nar.oxfordjournals.org/cgi/content/full/gkp1250/DC1)). All *Itpa^−/--^* primary MEFs at the second passage showed significantly longer doubling time (132.0 ± 14.6 h) than those from *Itpa^+/+^* (78.6 ± 10.1 h) and *Itpa^+/−^* (87.5 ± 14.3 h) embryos ([Figure 1](#F1){ref-type="fig"}C). There was no obvious difference in their morphology under phase contrast microscopy ([Supplementary Figure S1C](http://nar.oxfordjournals.org/cgi/content/full/gkp1250/DC1)). In Passage 5, we observed essentially the same proliferation deficiency in *Itpa^−/--^* MEFs and slightly increased numbers of senescence-associated β-galactosidase (SA-β-Gal)-positive cells in *Itpa^−/--^* MEFs (*Itpa^+/+^* versus *Itpa^−/--^*, 3.64% versus 7.74%; [Supplementary Figure S2A and B](http://nar.oxfordjournals.org/cgi/content/full/gkp1250/DC1)). Flow cytometry analysis of the cell cycle revealed that *Itpa^−/--^* MEFs exhibited a significant increase in the G2/M phase (*Itpa^+/+^* versus *Itpa^−/--^*, 28.4% versus 77.4%; [Figure 1](#F1){ref-type="fig"}D) and a slight increase in the sub G1 fraction (*Itpa^+/+^* versus *Itpa^−/--^*, 1.61% versus 5.51%; fraction M1 in [Figure 2](#F2){ref-type="fig"}A). There was an apparent increase in cells with an abnormally increased DNA content in *Itpa^−/--^* MEFs compared with *Itpa^+/+^* MEFs (fraction M3 in [Figure 2](#F2){ref-type="fig"}A), indicating that the G2/M phase shown in [Figure 1](#F1){ref-type="fig"}D might have contained some tetraploid cells at the G1 phase ([Figure 2](#F2){ref-type="fig"}B). There was no increase in dead cells detected as propidium iodide (PI)/Hoechst-double positive cells ([Supplementary Figure S2C](http://nar.oxfordjournals.org/cgi/content/full/gkp1250/DC1)). These results indicate that ITPA deficiency caused delay or arrest in cell-cycle progression. We further observed that exposure of *Itpa^−/--^*, but not *Itpa^+/+^*, *Itpa^+/−^* MEFs, to sodium nitrite (NaNO~2~), which causes predominant deamination of purine bases ([@B18]), resulted in growth suppression without inducing cell death ([Supplementary Figure S2C](http://nar.oxfordjournals.org/cgi/content/full/gkp1250/DC1)).

We next examined for chromosomal abnormalities in mitotic cells ([Figure 3](#F3){ref-type="fig"}A). As shown in [Figure 3](#F3){ref-type="fig"}B, chromosomal structural abnormalities were more frequently observed in *Itpa^−/--^* MEFs than in *Itpa^+/+^* MEFs, especially premature centromere separation (3.33 times more common), chromatid gaps (2.04 times) and chromatid breakages (1.52 times). Moreover, the percentage of cells with abnormal chromosomes in *Itpa^−/--^* primary MEFs was significantly higher than among *Itpa^+/+^* and *Itpa^+/−^* MEFs. There was an increase in ploidy abnormalities among *Itpa^−/--^* primary MEFs ([Figure 2](#F2){ref-type="fig"}B): thus 41.2% in the mitotic fraction exhibited tetraploidy, while about 25% of mitotic fractions in *Itpa^+/+^* and *Itpa^+/−^* MEFs were detected as tetraploids. This confirmed the increase in ploidy among *Itpa^−/--^* MEFs.

Because chromatid gaps or breakages are most likely to be caused by the accumulation of single- or double-strand breaks in DNA, we examined levels of single-strand breaks (SSBs) in DNA using an antibody against single-stranded (ss) DNA (anti-ssDNA) ([Figure 3](#F3){ref-type="fig"}C) ([@B16]). Immunofluorescence microscopy with anti-ssDNA revealed that the percentages of immunoreactive nuclei in *Itpa^−/--^* primary MEFs were significantly higher than in *Itpa^+/+^* MEFs ([Figure 3](#F3){ref-type="fig"}D). Thus, more SSBs had accumulated in the DNA of *Itpa^−/--^* primary MEFs. Furthermore, the nuclei were heterogeneous in *Itpa^−/--^* MEFs and both the small and large nuclei exhibited ssDNA immunoreactivity ([Figure 3](#F3){ref-type="fig"}C).

Immortalization of *Itpa^−/--^* MEFs reversed the ITPA-deficient phenotypes with increased ITP/IDP-hydrolyzing activity
-----------------------------------------------------------------------------------------------------------------------

To obtain established cell lines with ITPA deficiency, spontaneously-immortalized MEFs were isolated after 30--40 passages of each primary MEF line. We noticed that each immortalized MEF population showed the same proliferation rate, irrespective of their genotype ([Figure 4](#F4){ref-type="fig"}A). The extent of chromosomal abnormalities ([Figure 4](#F4){ref-type="fig"}B), and both levels of dI (2.49 ± 0.24 dI residues per 10^6^ nucleosides) and ssDNA (positive in 6.17 ± 0.68% of cells) in nuclear DNA ([Figure 7](#F7){ref-type="fig"}E and F) were similarly decreased in immortalized *Itpa^−/--^* MEFs. Furthermore, the G1 phase fraction increased significantly in immortalized *Itpa^−/--^* MEFs ([Figure 5](#F5){ref-type="fig"}A) compared with primary MEFs ([Figure 2](#F2){ref-type="fig"}A). Because the percentages of tetraploids were significantly higher in both primary and immortalized *Itpa*^−/--^ MEFs than *Itpa^+/+^* or *Itpa^+/−^* MEFs ([Figures 2](#F2){ref-type="fig"}B and [5](#F5){ref-type="fig"}B), the G2/M fraction in immortalized *Itpa^−/--^* MEFs was apparently less than in primary *Itpa^−/--^* MEFs.

To test whether any backup enzyme for ITPA deficiency might exist in the immortalized *Itpa^−/--^* MEFs, we measured ITP-hydrolyzing activity in extracts prepared from embryos and immortalized MEFs ([Table 1](#T1){ref-type="table"}, [Supplementary Figure S3](http://nar.oxfordjournals.org/cgi/content/full/gkp1250/DC1)). There was no detectable ITP-hydrolyzing activity in extracts prepared from *Itpa^−/--^* embryos, but a significantly high rate was detected in *Itpa^+/+^* embryos, thus confirming ITPA deficiency in *Itpa^−/--^* embryos. We also confirmed that *Itpa^−/--^* primary MEFs (Passage 3) did not generate IMP from ITP. On the other hand, we detected substantial activity in extracts from immortalized *Itpa^−/--^* MEFs, although the levels were less than 20% of that detected in immortalized *Itpa^+/+^* MEFs or embryos. We then measured IDP-hydrolyzing activity in these extracts ([Table 1](#T1){ref-type="table"}, [Supplementary Figure S3](http://nar.oxfordjournals.org/cgi/content/full/gkp1250/DC1)). Levels were increased both in *Itpa^+/+^* and *Itpa^−/--^* MEFs during immortalization and the activity was more significantly increased in immortalized *Itpa^−/--^* MEFs than in immortalized *Itpa^+/+^* MEFs. These results strongly suggest that an increased expression of IDP or ITP-hydrolyzing enzyme(s) blocked or reversed the ITPA-deficient phenotypes observed in primary *Itpa^−/--^* MEFs. Table 1.Specific ITP/IDP hydrolysis activity in crude-cell extracts prepared from embryos and immortalized MEFsIsolate no. 1Isolate no. 2Cell extractSubstrateSpecific activity (u/µg)SDSpecific activity (u/µg)SD*Itpa^+/+^* embryoITP6.340.84.080.7*Itpa^+/+^* embryoIDP0.840.21.260.4*Itpa^+/+^* iMEFITP6.420.97.241.0*Itpa^+/+^* iMEFIDP3.490.53.680.4*Itpa^−/--^* embryoITPNDND*Itpa^−/--^* embryoIDP0.860.31.850.4*Itpa^−/--^* iMEFITP1.090.11.360.3*Itpa^−/--^* iMEFIDP5.900.57.851.5[^3]

NUDT16 with strong (deoxy)inosine diphosphatase activity is responsible for cancellation of ITPA-deficient phenotypes and an increase in ITP/IDP-hydrolyzing activity during immortalization
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

We recently found that the human NUDT16 (nudix \[nucleoside diphosphate linked moiety X\]-type motif 16) protein, identified as an ITP/XTP/GTP binding protein, has strong IDP and 2′-deoxy-IDP (dIDP)-hydrolyzing activities with weak ITP/dITP-hydrolyzing activities. We also confirmed that mouse NUDT16 protein has essentially the same activities as the human protein (Iyama *et al.*, in preparation). Therefore, we compared *Nudt16* mRNA levels among primary and immortalized *Itpa^+/+^* or *Itpa^−/--^* MEFs ([Figure 6](#F6){ref-type="fig"}A). Quantitative real-time reverse transcription polymerase chain reaction (RT--PCR) analysis revealed that the expression levels of *Nudt16* mRNA were similar between primary MEFs derived from *Itpa^+/+^* and *Itpa^−/--^* embryos. In contrast, the expression levels of *Nudt16* mRNA in immortalized *Itpa^−/--^* MEFs were more than 3-fold higher than those of primary *Itpa^−/--^* MEFs and more than 2-fold higher than those in immortalized *Itpa^+/+^* MEFs ([Figure 6](#F6){ref-type="fig"}A). Significantly increased expression of NUDT16 protein in immortalized *Itpa^−/--^* MEFs was confirmed by western blotting analysis of crude cell extracts prepared from these MEFs ([Figure 6](#F6){ref-type="fig"}B). We thus conclude that the increased expression of *Nudt16* in immortalized *Itpa^−/--^* MEFs is responsible for the increase in ITP/IDP-hydrolyzing activity compared with immortalized *Itpa^+/+^* MEFs.

To examine the contribution of NUDT16 to the reversal of ITPA-deficient phenotypes in immortalized *Itpa^−/--^* MEFs, knockdown of *Nudt16* mRNA expression was performed using a mixture of two different *Nudt16* silencing (si)RNAs. This treatment caused an efficient reduction of both *Nudt16* mRNA and protein levels to less than 20% of the levels seen in controls ([Figure 7](#F7){ref-type="fig"}A and B). Knockdown of *Nudt16* expression in immortalized *Itpa^−/--^* but not in *Itpa^+/+^* MEFs caused a significant reduction in proliferation rate ([Figure 7](#F7){ref-type="fig"}C), as observed in primary *Itpa^−/--^* MEFs ([Figure 1](#F1){ref-type="fig"}C).

We next measured inosine levels in cellular RNA with or without *Nudt16* siRNAs. Immortalized *Itpa^−/--^* MEFs contained 516.8 ± 22.3 inosine residues per 10^6^ guanosine residues of RNA in the presence of control siRNA which was slightly lower than that in *Itpa^−/--^* embryos (567.3 ± 41.4 residues per 10^6^ guanosine), and *Nudt16* expression knockdown increased the level to 648.5 ± 01.7 residues per 10^6^ guanosine residues of RNA ([Figure 7](#F7){ref-type="fig"}D). As shown in [Figure 7](#F7){ref-type="fig"}E, immortalized *Itpa^−/--^* MEFs contained 2.49 ± 0.24 dI residues per 10^6^ nucleosides in nuclear DNA in the presence of control siRNA which was equivalent to that in immortalized *Itpa^+/+^* MEFs (2.74 ± 0.17 dI residues per 10^6^ nucleosides). *Nudt16* expression knockdown in immortalized *Itpa^−/--^* MEFs significantly increased the level more than 5-fold (12.73 ± 0.99 residues per 10^6^ nucleosides). In contrast, knockdown of *Nudt16* expression in immortalized *Itpa^+/+^* MEFs did not affect the level of dI accumulation in nuclear DNA (2.96 ± 0.3 dI residues per 10^6^ nucleosides).

Knockdown of *Nudt16* expression significantly increased the immunoreactivity against ssDNA in immortalized *Itpa^−/--^* MEFs ([Figure 7](#F7){ref-type="fig"}F). Moreover, karyotyping of immortalized *Itpa^−/--^* MEFs after *Nudt16* expression knockdown revealed a significant increase in chromosome structural abnormalities, such as chromatid gaps, premature separation and triradial forms compared with controls ([Figure 7](#F7){ref-type="fig"}G).

Thus, increased expression of *Nudt16* was responsible for reversal of the ITPA-deficient phenotypes with reduction of dI accumulation in nuclear DNA but not inosine in cellular RNA.

DISCUSSION
==========

ITPA deficiency increases the accumulation of deoxyinosine in nuclear DNA resulting in severe cellular dysfunction
------------------------------------------------------------------------------------------------------------------

Here, we showed for the first time that ITPA deficiency caused a significant accumulation of dI in the nuclear DNA of mouse embryos, most of which are likely to die around the time of birth. In wild-type embryos, fewer than three residues of dI per 10^6^ nucleosides, corresponding to about 20 000 residues in a whole cell, were detected in nuclear DNA, whereas about 20 residues of dI per 10^6^ nucleosides reaching more than 10^5^ residues per cell accumulated in *Itpa^−/--^* embryos. These results indicate that both spontaneous generation of dITP and incorporation of dITP into DNA occurred at significantly high frequencies. Thus, ITPA deficiency caused severe cellular dysfunction resulting in perinatal lethality. Indeed, we demonstrated that this deficiency in primary MEFs increased the accumulation of SSBs in nuclear DNA detected as ssDNA immunoreactivity and as chromosomal abnormalities such as chromatid/chromosome gaps or breaks. There was also premature centromere separation. All these chromosomal anomalies are likely to cause G2/M arrest thus suppressing cell proliferation, as observed in primary *Itpa^−/--^* MEFs.

In *E. coli*, the lethality of *rdgB recA* or *rdgB recBC* double mutants, the former-encoding inosine triphosphatase, is suppressed by the inactivation of endonuclease V (EndoV) ([@B12]), which cleaves at the second phosphodiester bond at 3′ to dI and initiates nucleotide excision repair ([@B19]). It is likely that an inosine triphosphatase deficiency in *E. coli* results in the accumulation of its substrate nucleotides, dITP in the nucleotide pools, thus causing an increased accumulation of dI into DNA. Further excision repair initiated by EndoV leads to chromosomal fragmentation in *recA* or *recBC* mutants.

In mammals, there are at least two enzymes that might be involved in excision repair of dI: the mammalian homolog of EndoV and alkyladenine DNA glycosylase (AAG) which can excise hypoxanthine, a deaminated adenine base ([@B20; @B21; @B22; @B23; @B24]). Because mammalian cells are likely to be less efficient in recombination repair than *E. coli* ([@B25]), ITPA deficiency itself thus causes severe phenotypes with massive generation of SSBs in DNA, likely caused by efficient excision repair of dI or hypoxanthine.

In primary *Itpa^−/--^* MEFs, increased frequency of chromosomal abnormalities such as chromatid/chromosome gaps or breaks might result from increased SSB accumulation in nuclear DNA, which is likely to be caused by excision repair of accumulated dI in nuclear DNA. It is noteworthy that exposure of peripheral lymphocytes to ITP or IDP in culture were reported to cause chromosome aberrations such as chromatid breaks and gaps ([@B26]) and sister chromatid exchange ([@B27]). Although the precise mechanism inducing chromosome aberration by ITP or IDP is not known, exposure to a high concentration of ITP or IDP might also result in an increase of dI in nuclear DNA, thus increasing SSBs and chromosome abnormalities as observed in *Itpa^−/--^* primary MEFs. Moreover, both ITPA deficiency and exposure to ITP or IDP increase premature centromere separation ([@B26]). Increased inosine levels in cellular RNA prepared from *Itpa^−/--^* embryos indicated that the ITP level was also significantly increased in the absence of ITPA. Therefore, these chromosomal abnormalities might be caused by the increased level of ITP in nucleotide pool. Because sister chromatid cohesion is established by a cohesin complex composed of Rad21, Smc1α, Smc3 and two Scc3 orthologs, SA1 and SA2 ([@B28],[@B29]) and whose reaction requires ATP, ITP might compete with ATP to disrupt sister chromatid cohesion, thus resulting in premature centromere separation and inappropriate chromatid separation.

Increased expression of *Nudt16* suppresses the ITPA-deficient phenotype during immortalization
-----------------------------------------------------------------------------------------------

During immortalization of *Itpa^−/--^* MEFs, most of the ITPA-deficient phenotype characteristics, such as prolonged doubling time, G2/M arrest, SSBs accumulation, chromosome abnormalities were canceled efficiently. This was accompanied by a significant reduction of dI accumulation in nuclear DNA. The inosine level in cellular RNA was still high in immortalized *Itpa^−/--^* MEFs (516.8 ± 22.3 inosine residues per 10^6^ guanosine residues) as much as seen in *Itpa^−/--^* embryos (567.3 ± 41.4 inosine residues per 10^6^ guanosines), thereby indicating that the ITPA-deficient phenotypes are most likely to be attributed to the increased accumulation of dI in nuclear DNA.

We identified the human NUDT16 protein (Iyama *et al.*, manuscript in preparation) as a dIDP/IDP-hydrolyzing enzyme, which can bind ITP/XTP/GTP and efficiently hydrolyzes dIDP/IDP, and to a lesser extent dITP/ITP, to dIMP/IMP. In the present study, we found that the levels of mouse *Nudt16* mRNA and NUDT16 protein were significantly higher in immortalized *Itpa^−/--^* MEFs than in immortalized wild-type MEFs or primary *Itpa^−/--^* MEFs. Because knockdown of *Nudt16* expression efficiently reproduced the ITPA-deficient phenotypes accompanied by significant increases of dI in nuclear DNA, and to a lesser extent of inosine in cellular RNA, we conclude that NUDT16 and ITPA play a dual protective role for eliminating dITP/ITP and dIDP/IDP from nucleotide pools in mammals.

ITP can be hydrolyzed slowly to IDP by ATPase or other nucleoside triphosphatases ([@B11],[@B30]), so increased dIDP hydrolysis in immortalized *Itpa^−/--^* MEFs is likely to be sufficient to eliminate dITP from the nucleotide pools. Moreover, ITP can be generated in a variety of tissue extracts as well as in erythrocytes ([@B31]). We reported previously that ITP accumulated in erythrocytes but not in tissues including the heart and liver derived from *Itpa^−/--^* mice, whereas IMP accumulated markedly in RNA prepared from the latter ([@B6]). Because both RNA and DNA synthesis takes place in the latter tissues, DNA and RNA polymerases are likely to utilize ITP and dITP efficiently as nucleotide precursors, thereby consuming most of the ITP or dITP that accumulates in the nucleotide pools in the absence of ITPA.

Considering the likely source of ITP or dITP in the nucleotide pools, IMP generated from AMP by AMP deamination must be the most relevant precursor, because most cells can synthesize IDP or ITP from IMP ([@B31]) and IDP may be converted to dIDP by ribonucleotide reductase, thus generating dITP ([@B21]). To minimize accumulation of ITP or dITP in the nucleotide pools, hydrolysis of IDP or dIDP to the corresponding monophosphates catalyzed by NUDT16 is likely to be as critical as is any hydrolysis of ITP or dITP to the corresponding monophosphates.

In the present study, we showed that increased expression of NUDT16 in *Itpa^−/--^* immortalized MEFs is sufficient to cancel the ITPA-deficient phenotypes observed in *Itpa^−/--^* embryos or primary MEFs, suggesting that the lower expression level of NUDT16 in normal tissues may be why any ITPA deficiency causes such severe phenotypes. On the other hand, ITPA deficiency in humans is likely to be related to azathioprine intolerance in patients with inflammatory bowel disease, but does not cause any severe phenotype ([@B32; @B33; @B34]), compared with the *Itpa^−/--^* mice. It is possible that human NUDT16 expression might be higher than that in mouse, thus compensating for any ITPA deficiency.

Identification of NUDT16 as a backup enzyme for ITPA deficiency in mice will shed light on the mechanisms that enable humans to be resistant to ITPA deficiency. Towards this goal, it is important to know the relative expression of ITPA and NUDT16 in human cells and organs, and to characterize the enzymatic properties of NUDT16.
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